We are live on ! Find out more
LPCN icon

Lipocine
LPCN

53 hedge funds and large institutions have $94.3M invested in Lipocine in 2016 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 17 increasing their positions, 17 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

150% more first-time investments, than exits

New positions opened: 10 | Existing positions closed: 4

147% more call options, than puts

Call options by funds: $672K | Put options by funds: $272K

13% more funds holding

Funds holding: 47 → 53 (+6)

0% more repeat investments, than reductions

Existing positions increased: 17 | Existing positions reduced: 17

21% less capital invested

Capital invested by funds: $119M → $94.3M (-$24.5M)

67% less funds holding in top 10

Funds holding in top 10: 3 → 1 (-2)

Holders
53
Holders Change
+6
Holders Change %
+12.77%
% of All Funds
1.41%
Holding in Top 10
1
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-66.67%
% of All Funds
0.03%
New
10
Increased
17
Reduced
17
Closed
4
Calls
$672K
Puts
$272K
Net Calls
+$400K
Net Calls Change
-$286K

Top Buyers

1
GGHC
Gilder Gagnon Howe & Co
New York
+$1.52M
2
TCM
Tang Capital Management
California
+$1M
3
FCMI
Foresite Capital Management III
California
+$674K
4
BG
BlackRock Group
United Kingdom
+$623K
5
Vanguard Group
Vanguard Group
Pennsylvania
+$549K

Top Sellers

1
KCM
Kingdon Capital Management
New York
-$1.86M
2
Renaissance Technologies
Renaissance Technologies
New York
-$1.61M
3
LOAMU
Lombard Odier Asset Management (USA)
New York
-$923K
4
VAM
Visium Asset Management
New York
-$733K
5
ISL
Ingalls & Snyder LLC
New York
-$389K
Name Holding Trade Value Shares
Change 		Change in
Stake
California Public Employees Retirement System
26
California Public Employees Retirement System
California
$467K – – –
Northern Trust
27
Northern Trust
Illinois
$406K -$70.1K -411 -15%
OAM
28
Oxford Asset Management
United Kingdom
$388K -$164K -962 -30%
LCM
29
Landscape Capital Management
New Jersey
$385K +$380K +2,229 New
CS
30
Credit Suisse
Switzerland
$372K +$252K +1,478 +218%
BFA
31
BlackRock Fund Advisors
California
$361K -$27.3K -160 -7%
UBS Group
32
UBS Group
Switzerland
$336K +$311K +1,820 +1,422%
Millennium Management
33
Millennium Management
New York
$328K +$325K +1,903 New
Goldman Sachs
34
Goldman Sachs
New York
$326K +$205K +1,202 +175%
PPA
35
Parametric Portfolio Associates
Washington
$308K +$304K +1,783 New
Morgan Stanley
36
Morgan Stanley
New York
$281K +$211K +1,235 +312%
JP Morgan Chase
37
JP Morgan Chase
New York
$226K +$223K +1,308 New
SCM
38
Segantii Capital Management
Hong Kong
$219K +$211K +1,235 New
Renaissance Technologies
39
Renaissance Technologies
New York
$195K -$1.61M -9,412 -89%
CG
40
Cutler Group
California
$182K +$159K +931 +722%
Nomura Holdings
41
Nomura Holdings
Japan
$155K +$153K +899 New
State Street
42
State Street
Massachusetts
$135K – – –
Deutsche Bank
43
Deutsche Bank
Germany
$105K -$30.5K -179 -23%
Simplex Trading
44
Simplex Trading
Illinois
$58K +$55.5K +325 +2,708%
LTFS
45
Ladenburg Thalmann Financial Services
Florida
$43K – – –
BIM
46
BlackRock Investment Management
Delaware
$26K -$1.02K -6 -4%
TRCT
47
Tower Research Capital (TRC)
New York
$20K +$19.8K +116 New
BA
48
BlackRock Advisors
Delaware
$17K – – –
AIM
49
Advantage Investment Management
Iowa
$15K – – –
Citigroup
50
Citigroup
New York
$10K -$3.24K -19 -23%
1
2
3

LPCN Hedge Fund Activity: Q1 2016 in Review

53 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Lipocine (LPCN) for Q1 2016, worth a combined $94.3M — down 21% from $119M a quarter earlier.

Buyers outnumbered sellers: 10 funds opened new LPCN positions and 4 closed out — a net gain of 6 holders — while 17 added to existing stakes and 17 trimmed.

The largest buyer was Gilder Gagnon Howe & Co, adding an estimated $1.52M. The largest seller was Kingdon Capital Management, cutting an estimated $1.86M.

  • 53 institutional investors held Lipocine (LPCN) as of Q1 2016, up from 47 in Q4 2015.
  • Funds reported $94.3M of Lipocine stock for Q1 2016, down 21% quarter-over-quarter.
  • 10 funds opened new Lipocine positions in Q1 2016 and 4 closed out, a net change of +6 holders.
  • The largest Lipocine buyer in Q1 2016 was Gilder Gagnon Howe & Co, an estimated $1.52M added.
  • The largest Lipocine seller in Q1 2016 was Kingdon Capital Management, an estimated $1.86M sold.

Based on aggregated 13F filings for Q1 2016.